LDS/Medical Tests/Hemoglobin S, Screen, Blood

Hemoglobin S, Screen, Blood

The adult hemoglobin (HbA) is composed of two alpha and two beta subunits, each consisting of a polypeptide and heme molecule. In hemoglobin S, the 6th amino acid of the beta chain, glutamic acid is replaced by valine due mutation (GAG to GTC). At lower oxygen tension, hemoglobin S is vulnerable to polymerization, resulting in sickle-shaped red cells. The substantial presence of hemoglobin S in the blood results in sickle cell disease. The disease is inherited in an autosomal recessive fashion. Mutation in both copies of the gene results in severe sickle cell anemia while a mutation in only one copy of the gene causes sickle cell trait which is less severe as compared to fulminant sickle cell anemia. The prevalence of sickle cell disease is alarmingly high with almost one hundred thousand people in the US being affected. The prevalence is higher in African American births with a prevalence of 1 in 13 live births.

Sickle cell disease possesses a huge risk due to the stiffness in the red blood cells caused by polymerized hemoglobin S. There is an enhanced adhesiveness of red cells to each other resulting in aggregate formation throughout the blood vessels. Importantly, these sickled red cells cannot pass through the tiny capillaries in the tissues and thus occlude them increasing the risk of ischemia-induced hypoxia and cell death. Even if the occlusion is relieved, there are higher chances of ischemia-reperfusion injury to the tissues. Other secondary consequences include platelet adhesion, hypercoagulability, neutrophil adherence, and nitric oxide binding. Sickle cell disease significantly reduces the life span by nearly 25-30 years and currently, there is no definite treatment, however, symptomatic treatment does exist. It is therefore very essential to diagnose individuals with hemoglobin S inheritance.

  • As an aid in in the diagnosis of sickle cell disease
  • To differentiate the sickle-cell trait from sickle-cell anemia
  • Aids in screening neonates and family members at risk
A positive result is indicated by turbid solution after a reaction with sodium hydrosulfite. The absence of any turbidity indicates a negative test. However, a negative test is encountered in sickle cell trait (heterozygous) and must be confirmed by hemoglobin electrophoresis.

Negative

Hemoglobin S solubility test by reducing agent (sodium hydrosulfite or dithionite).

Whole blood (EDTA).

Stability

  • Ambient: 4 hrs.
  • Refrigerated (preferred): 7-14 days
  • Frozen: unstable
Hemoglobin S sickling test, Hemoglobin electrophoresis, CBC.
1-2 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login